Cure Pharmaceutical Holding Corp. is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Cure Pharmaceutical Holding Corp. has published a filing in the past twelve months. The most recent one dates from 15 September 2022.
Since 2019, the database holds no purchases and 40 sales by insiders of the company.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2023 · cache
25 of 56 declarations
Cure Pharmaceutical Holding Corp. is a company focused on developing innovative pharmaceutical solutions. It specializes in creating advanced drug formulations and delivery technologies.